Discover how targeted therapies are transforming precision oncology by matching cancer treatments to genetic mutations, enabling more personalized and effective care.
Learn how targeted therapies match drugs to cancer-driving mutations, advancing precision oncology and improving treatment outcomes.
Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case.
Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring.

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.